Using Tegoprubart to Support Genetically Modified Xenotransplant

Using Tegoprubart to Support Genetically Modified Xenotransplant

Source: CGTLive™

David-Alexandre Gros, MD, the chief executive officer of Eledon Pharmaceuticals, discussed the company’s investigational monoclonal antibody and its use along with EGenesis porcine kidney transplant product.

This is the second part of an interview with David-Alexandre Gros, MD. For the first part, click here.
David-Alexandre C. Gros, MD
Credit: Eledon
EGenesis's EGEN-2784 is a porcine kidney that features a number of genetic modifications intended to pre… [5122 chars]

Read more